MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.

TSXV:MIR - Post by User

MedMira Inc > MIR poised for massive revenue growth in 2021

<< Previous

Bullboard Posts

Next >>

Post by Jennifer2020on Dec 28, 2020 12:02am

178 Views

Post# 32186391

MIR poised for massive revenue growth in 2021

An FDA EUA for RealCovid 19 and an announcement of another $723,000 in income developing an ANTIGEN/Influenza 1 & 2 combo test will see huge orders sure to follow.

MIR will be looking at 10's of millions of revenue instead of 100's of thousands from the past.

This is an example of the revenue potential out there from governments, airport authouritys and business interests:
As a readerless antigen test, the QuickVue test may be most similar to the BinaxNow from Abbott Laboratories. To date, the federal government has supported the Abbott test with $760 million in funding and distributed 80 million tests.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects